Calamos Advisors
PEPLU

Calamos Advisors’s PepperLime Health Acquisition Corporation Unit PEPLU Stock Holding History

Calamos Advisors’s Portfolio PEPLU Stock Details PEPLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-700,000
Closed -$6.96M – 1582
2022
Q2 		$6.96M Hold
700,000
– – 0.03% 606
2022
Q1 		$7.12M Hold
700,000
– – 0.03% 611
2021
Q4 		$7.13M Buy
+700,000
New +$6.99M 0.03% 608

Other funds holding PEPLU

SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CCM
Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return

Calamos Advisors's PEPLU Position: Q3 2022 in Review

Calamos Advisors sold out of PepperLime Health Acquisition Corporation Unit (PEPLU) in Q3 2022, closing a stake of 700,000 shares — an estimated $6.96M sold.

Calamos Advisors first reported a position in PEPLU in Q4 2021 and held it in 3 quarters. The position peaked at $7.13M in Q4 2021. 11 funds tracked by Wall St. Rank hold PEPLU as of Q3 2022.

  • Calamos Advisors reported no remaining PepperLime Health Acquisition Corporation Unit position as of Q3 2022 after selling out during the quarter.
  • Calamos Advisors sold 700,000 PepperLime Health Acquisition Corporation Unit shares in Q3 2022, an estimated $6.96M.
  • Calamos Advisors first reported a position in PepperLime Health Acquisition Corporation Unit in Q4 2021 and held it in 3 quarters.
  • Calamos Advisors's PepperLime Health Acquisition Corporation Unit position peaked at $7.13M in Q4 2021.
  • 11 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Unit as of Q3 2022.

Based on Calamos Advisors's 13F filing for Q3 2022, filed 24 Oct 2022.